EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Inpatient Erythropoiesis-Stimulating Agent Use and Anemia-Related Outcomes in Patients With Advanced Chronic Kidney Disease

Andrew Dang, Ariadna Cervantes, Tomona Iso iD, Lisa Hong iD

Journal of Pharmacy Practice · 02.11.2026

DOI: 10.1177/08971900261503064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy Practice, online erschienen am 02.11.2026. Verfasst von Andrew Dang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Loma Linda University School of Pharmacy, Loma Linda, CA, USA. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inpatient erythropoiesis-stimulating agent (ESA) management varies across institutions and is often influenced by system-level prescribing constraints, but the clinical impact of ESA interruption during hospitalization is unclear. This study evaluated anemia-related outcomes associated with shorter vs longer durations of inpatient ESA interruption in hospitalized patients with chronic kidney disease (CKD) in the setting of an electronic order entry restriction. This retrospective cohort study included hospitalized adult patients receiving ESA treatment prior to admission for anemia of CKD. Patients were grouped by duration of inpatient ESA interruption. The primary outcome was packed red blood cell (PRBC) transfusion during hospitalization. Secondary outcomes included hemoglobin (Hgb) below 7 g/dL, rehospitalization for anemia, bleeding, and mortality within 90 days post-discharge, time to transfusion, and hospital length of stay. Seventy-four patients met inclusion criteria. A higher proportion of patients with ≥10 days of ESA interruption required PRBC transfusion compared to those with

Schlagwörter

Stichwörter der Autor:innen

internal medicinenephrologypharmacy administrationtransitions of care

Autor:innen und Institutionen

  • Department of Pharmacy Practice, Loma Linda University School of Pharmacy, Loma Linda, CA, USA.

ORCID-Profile: Tomona Iso, Lisa Hong

Zitieren

APA

Dang, A., Cervantes, A., Iso, T., & Hong, L. (2026). Inpatient Erythropoiesis-Stimulating Agent Use and Anemia-Related Outcomes in Patients With Advanced Chronic Kidney Disease. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900261503064

Vancouver

Dang A, Cervantes A, Iso T, Hong L. Inpatient Erythropoiesis-Stimulating Agent Use and Anemia-Related Outcomes in Patients With Advanced Chronic Kidney Disease. Journal of Pharmacy Practice. 2026. doi:10.1177/08971900261503064

BibTeX
@article{Dang2026,
  author = {Dang, Andrew and Cervantes, Ariadna and Iso, Tomona and Hong, Lisa},
  title = {Inpatient Erythropoiesis-Stimulating Agent Use and Anemia-Related Outcomes in Patients With Advanced Chronic Kidney Disease},
  journal = {Journal of Pharmacy Practice},
  year = {2026},
  doi = {10.1177/08971900261503064}
}
Kostenlos starten →